Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.
Imai Y, Tamura S, Tanaka H, Hiramatsu N, Kiso S, Doi Y, Inada M, Nagase T, Kitada T, Imanaka K, Fukuda K, Takehara T, Kasahara A, Hayashi N. Imai Y, et al. Among authors: doi y. J Viral Hepat. 2010 Mar;17(3):185-91. doi: 10.1111/j.1365-2893.2009.01163.x. Epub 2009 Aug 26. J Viral Hepat. 2010. PMID: 19709362
Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin.
Oze T, Hiramatsu N, Song C, Yakushijin T, Iio S, Doi Y, Oshita M, Hagiwara H, Mita E, Ito T, Inui Y, Hijioka T, Tamura S, Yoshihara H, Inoue A, Imai Y, Hayashi E, Kato M, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Tatsumi T, Kiso S, Kanto T, Kasahara A, Hayashi N, Takehara T. Oze T, et al. Among authors: doi y. J Gastroenterol. 2012 Mar;47(3):334-42. doi: 10.1007/s00535-011-0498-3. Epub 2011 Nov 23. J Gastroenterol. 2012. PMID: 22109353
Recombinant interferon-alpha-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study.
Imai Y, Kawata S, Tamura S, Ito N, Seki K, Nishiuchi M, Shinji Y, Kiriyama K, Himeno S, Minami Y, Kashihara T, Kawakami F, Maeda H, Yabuuchi I, Nishioka M, Shirai Y, Fukuda K, Kiso S, Ito T, Igura T, Doi Y, Matsuzawa Y. Imai Y, et al. Among authors: doi y. Liver. 1997 Apr;17(2):88-92. doi: 10.1111/j.1600-0676.1997.tb00786.x. Liver. 1997. PMID: 9138278 Clinical Trial.
Ensitrelvir treatment-emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial.
Uehara T, Yotsuyanagi H, Ohmagari N, Doi Y, Yamato M, Imamura T, Sakaguchi H, Fukushi A, Takeda Y, Baba K, Nobori H, Miyamoto T, Arita S, Dodo R, Shimba A, Fukao K, Shishido T, Tsuge Y, Mukae H. Uehara T, et al. Among authors: doi y. Antiviral Res. 2025 Jan 30:106097. doi: 10.1016/j.antiviral.2025.106097. Online ahead of print. Antiviral Res. 2025. PMID: 39892563 Free article.
A Novel Heterozygous and Pathogenic Variant of the HNF1B Gene Associated with Autosomal Dominant Tubulointerstitial Kidney Disease with a Broad Spectrum of Extrarenal Phenotypes: A Case Report.
Kaimori JY, Matsuda J, Jan A, Kawano Y, Kawaoka T, Asahina Y, Doi Y, Oka T, Nagata M, Ishihara Y, Miyashita Y, Asano T, Sakaguchi Y, Isaka Y. Kaimori JY, et al. Among authors: doi y. Intern Med. 2025 Jan 15. doi: 10.2169/internalmedicine.4548-24. Online ahead of print. Intern Med. 2025. PMID: 39814389 Free article.
Final Results of a Multicenter Prospective Study of Stereotactic Body Radiation Therapy for Previously Untreated Solitary Primary Hepatocellular Carcinoma (The STRSPH Study).
Sanuki N, Kimura T, Takeda A, Ariyoshi K, Oyamada S, Yamaguchi T, Tsurugai Y, Doi Y, Kokubo M, Imagumbai T, Katoh N, Eriguchi T, Ishikura S. Sanuki N, et al. Among authors: doi y. Int J Radiat Oncol Biol Phys. 2024 Dec 18:S0360-3016(24)03562-4. doi: 10.1016/j.ijrobp.2024.10.040. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39706374 Free article.
2,118 results